Xponance, Inc.

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-01
Total Holdings: 1,445
Total Value: 10340327523
Accession Number: 0001085146-25-002511
Form Type: 13F-HR
CIK: 0001637541
Manager Name: Xponance, Inc.

Data Enrichment

99% identified

1,428 identified17 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

1,445 positions • $10,340,327.523K total value

1,445 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 73 of 73

Sort by:

NEKTAR THERAPEUTICS

Shares:

12190(+2.5%)

Value:

$8.3M(-25.0%)

CHEGG, INC

Shares:

10009

Value:

$6.4M

Lyell Immunopharma, Inc.

Shares:

11269(+2.5%)

Value:

$6.1M(-13.9%)

Lineage Cell Therapeutics, Inc.

Shares:

12875(+23.1%)

Value:

$5.8M(+10.7%)

X4 Pharmaceuticals, Inc

Shares:

11046(+2.6%)

Value:

$2.6M(-66.9%)

Instrument	Shares		Other Manager	Value
Nektar Therapeutics(NKTRcusip640268108)	12.2K	QoQ +2.53% (-301) YoY NEW(+12.2K)	All Managers (Combined)	$8.3K	QoQ -25.03% (-$2.8K) YoY NEW(+$8.3K)
Chegg, Inc(CHGGcusip163092109)	10.0K	QoQ NEW(+10.0K) YoY NEW(+10.0K)	All Managers (Combined)	$6.4K	QoQ NEW(+$6.4K) YoY NEW(+$6.4K)
Lyell Immunopharma, Inc.(LYELcusip55083R104)	11.3K	QoQ +2.46% (-271) YoY +5.61% (-599)	All Managers (Combined)	$6.1K	QoQ -13.86% (-$976) YoY -74.51% (-$17.7K)
Lineage Cell Therapeutics, Inc.(LCTXcusip53566P109)	12.9K	QoQ +23.13% (+2.4K) YoY NEW(+12.9K)	All Managers (Combined)	$5.8K	QoQ +10.65% (+$560) YoY NEW(+$5.8K)
X4 Pharmaceuticals, Inc(XFORcusip98420X103)	11.0K	QoQ +2.65% (-286) YoY NEW(+11.0K)	All Managers (Combined)	$2.6K	QoQ -66.92% (-$5.3K) YoY NEW(+$2.6K)